These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 29856921

  • 21. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z, Mansour HM, Mulder T, McLean R, Langridge J, Hickey AJ.
    J Pharm Sci; 2010 Aug; 99(8):3398-414. PubMed ID: 20198688
    [Abstract] [Full Text] [Related]

  • 22. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 23. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Mar 20; 52(3):350-3. PubMed ID: 14993760
    [Abstract] [Full Text] [Related]

  • 24. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 25. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W, Rades T, Rantanen J, Yang M.
    Int J Pharm; 2019 Jun 30; 565():1-8. PubMed ID: 30999050
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 30; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H, Palakodaty S, Clark A, York P, Tzannis ST.
    Int J Pharm; 2004 Aug 20; 281(1-2):55-66. PubMed ID: 15288343
    [Abstract] [Full Text] [Related]

  • 28. Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.
    Khan I, Al-Hasani A, Khan MH, Khan AN, -Alam FE, Sadozai SK, Elhissi A, Khan J, Yousaf S.
    PLoS One; 2023 Aug 20; 18(3):e0281860. PubMed ID: 36913325
    [Abstract] [Full Text] [Related]

  • 29. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 30. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
    Ferdynand MS, Nokhodchi A.
    Drug Deliv Transl Res; 2020 Oct 01; 10(5):1418-1427. PubMed ID: 31933129
    [Abstract] [Full Text] [Related]

  • 31. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ, Lee HG, Kwon YB, Kim JY, Rhee YS, Chon J, Park ES, Kim DW, Park CW.
    Eur J Pharm Sci; 2018 May 30; 117():279-289. PubMed ID: 29510172
    [Abstract] [Full Text] [Related]

  • 32. Characterizing the Surface Roughness Length Scales of Lactose Carrier Particles in Dry Powder Inhalers.
    Tan BMJ, Chan LW, Heng PWS.
    Mol Pharm; 2018 Apr 02; 15(4):1635-1642. PubMed ID: 29490144
    [Abstract] [Full Text] [Related]

  • 33. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenbergerb H.
    Chem Pharm Bull (Tokyo); 2003 Dec 02; 51(12):1455-7. PubMed ID: 14646332
    [Abstract] [Full Text] [Related]

  • 34. Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI.
    Harjunen P, Lehto VP, Martimo K, Suihko E, Lankinen T, Paronen P, Järvinen K.
    Eur J Pharm Sci; 2002 Sep 02; 16(4-5):313-21. PubMed ID: 12208462
    [Abstract] [Full Text] [Related]

  • 35. Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.
    Hertel M, Schwarz E, Kobler M, Hauptstein S, Steckel H, Scherließ R.
    Int J Pharm; 2018 Jan 15; 535(1-2):59-67. PubMed ID: 29100914
    [Abstract] [Full Text] [Related]

  • 36. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 15; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 37. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W, Nokhodchi A.
    Pharm Res; 2013 Feb 15; 30(2):458-77. PubMed ID: 23070603
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.